Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: December 25, 2006
Last updated: December 26, 2006
Last verified: December 2006
The purpose of the study is to was to evaluate the anti bacterial efficacy of sustain-release Cetylpyridinium chloride varnish on orthodontic patients.

Condition Phase
Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Phase 1: To Evaluate the Antibacterial Efficacy of Sustained Release Cetylpyridinium Chloride Varnish in Orthodontic Patients

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 30

Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Exclusion Criteria:

  • Children under 12y old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00416286

Contact: Doron Harari, DMD 972-2-6776169

Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: Doron Harari, DMD Orthodontic department, Dental school Hadassah Ein Kerem
  More Information Identifier: NCT00416286     History of Changes
Other Study ID Numbers: 26-23.12.05-HMO-CTIL  26-23.12.05  code: 1371 
Study First Received: December 25, 2006
Last Updated: December 26, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
Cetylpyridinium chlorid
Sustained release
orthodontic patients
streptococcus mutans
Rate of bacterial load in saliva of orthodontic patients

Additional relevant MeSH terms:
Anti-Infective Agents, Local
Anti-Infective Agents processed this record on October 21, 2016